Cerved
PROVA ORA GRATIS
Logo Dante Labs Srl

Dante Labs Srl

Sede legale: Localita' Boschetto, SNC, 67100, L'Aquila (AQ)
P.IVA: 01987870662
72.11.00: Ricerca e sviluppo sperimentale nel campo delle biotecnologie
PROVA ORA GRATIS
Iscriviti gratis per sbloccare tutte le informazioni aziendali
Overview
Aziende simili
Persone
Valutazioni
News e media

Dati societari di
Dante Labs Srl

RICAVI 22.6 M €
TREND RICAVI -31.4%
P.IVA 01987870662
C. ATECO 72.11.00
DIPENDENTI 13
ANZIANITÁ 9 anni
Vedi più informazioni

Affidabilità creditizia di
Dante Labs Srl

Valuta la capacità di un soggetto di onorare gli impegni finanziari, aiutando a prevedere il rischio di inadempienza nei pagamenti.

Affidabilità creditizia
Vedi altre valutazioni

Persone in Dante Labs Srl

Presidente Consiglio Amministrazione
Nome e Cognome
emailATexample.com
+39 0123456789
Vedi altri contatti

Iscriviti ora
gratuitamente

Accedi a tutte le informazioni di Dante Labs Srl, di altre 6 milioni di imprese e 13 milioni di contatti con i prodotti Cerved pensati per te!

PROVA ORA GRATIS

Descrizione di Dante Labs Srl

We are the genome company. We use genome sequencing technology and interpretation so that you can make informed decisions about your health and your future. Dante Labs is the genome company. We are a leading global genomics and precision medicine company committed to advancing scientific innovation in healthcare, with the goal of improving human well-being and saving lives through a human approach to health. We are pioneers in providing genomic services and solutions, equipped with state-of-the-art technologies and bioinformatics proficiency. Contact us today to speak to one of our specialists, who will be happy to answer any of your questions. Introduction   Epilepsy - a condition that affects millions worldwide, causing recurrent seizures and significant challenges in daily life. In this blog post, we will delve into the world of epilepsy, its incidence, and most importantly, explore the groundbreaking role of Whole Genome Sequencing (WGS) analysis and the  Introduction   Every year, on February 14th, we come together to raise awareness for World Congenital Heart Defect (CHD) Awareness Day. This significant day serves as a reminder of the millions of children and adults around the world who are affected by CHD, as well as the importance of early detection, proper treatmen – Dante to utilize Amazon Bedrock to build state-of-the-art large language model (LLM) with broad genomic and clinical applications – – Amazon Bedrock will leverage Dante’s expertise with clinical interpretation and massive whole genome database – – Groundbreaking collaboration pioneering the use case for LLMs in perso Personalized medicine is opening new horizons in the field of patient care. Thanks to WGS analysis, it’s possible to achieve personalized diagnosis. Dante was pleased to have CNN host Anna Stewart at its whole genome sequencing lab in Dubai to discuss her results and the overall health benefits of sequencing your genome –––––––––––––––––––––– Dante’s whole genome sequencing laboratory in Dubai serves as a sequencing hub for the Eastern Hemisphere. In January, Dante Introduction Blood Cancer Day is a crucial reminder of the battles millions face worldwide and the strides we are making toward better diagnosis and treatment. Hematologic conditions, including different forms of anemia, bleeding disorders, and blood cancers like leukemia and lymphoma, are frequently driven by complex NEW YORK, March 20, 2023 (PR NEWSWIRE) -- Dante Genomics, a global leader in genomics and precision medicine, launched today the beta version of Avanti, the Company’s proprietary B2B software for variant interpretation and report writing at scale. Avanti provides clinicians, geneticists and researchers with a plug-and- Meaningful Gift: Giving a Whole Genome Sequencing Test as a gift shows your mom how much you care about her health and well-being. – Dante Genomics uses the 1health.io platform to accelerate their go to market strategy and expand availability in all 50 states using the 1health online prescription services –   NEW YORK, December 7, 2022 – 1health.io Inc. (“1health”), an industry-leading software company that empowers laboratories to launch new test DUBAI, UAE and NEW YORK, June 20, 2023 /PRNewswire/ — With the aim of bringing the best of scientific solutions in healthcare to the MENA region, Seed Group, a company of the Private Office of Sheikh Saeed Bin Ahmed Al Maktoum, has announced a strategic partnership with New York-based biotechnology company Dante Genomi Introduction   Our senses—sight, hearing, touch, taste, and smell—are the windows through which we experience the world. They allow us to connect with our surroundings, communicate with others, and savor life's pleasures. But what happens when these sensory pathways are compromised? Conditions like hearing loss, vision – Highly coveted Innovation Grant by the Italian Government will measure impact of whole genome sequencing and pharmacogenomics starting from a specific population of cancer patients – NEW YORK, April 27, 2023 /PRNewswire/ -- Dante Genomics, a global leader in genomics and precision medicine, today announced it has bee Introduction   As we commemorate World Obesity Day, we want to take time to reflect on the complexities of obesity and the vital role that genetic testing plays in understanding and preventing this pervasive health issue. Obesity goes beyond mere aesthetics, posing serious medical risks such as heart disease, diabetes, Introduction   Every year, on February 15th, the world comes together to observe International Childhood Cancer Day. This day serves as a reminder of the importance of early detection, effective treatment, and most importantly, prevention of childhood cancer. In recent years, advancements in genetic testing, such as Wh Introduction   Every year, on November 14th, the world comes together to observe World Diabetes Day. This global awareness campaign aims to shed light on the growing prevalence of diabetes and the importance of early detection and prevention. In the pursuit of this goal, cutting-edge technology is playing a pivotal rol Introduction June 18th marks International Panic Day, a day dedicated to raising awareness about the struggles with mental illness, particularly panic disorders. Panic disorders are a type of anxiety disorder characterized by sudden and repeated episodes of intense fear accompanied by physical symptoms such as heart pa Introduction   In the world of genetics, there's one field that plays a pivotal role in unraveling the mysteries of our DNA - bioinformatics. As technology advances, whole genome sequencing has become an indispensable tool for understanding our genetic makeup. The true power of bioinformatics lies in the ability to tra Introduction As we celebrate the International Day of Biological Diversity, it's essential to reflect on the pressing need for innovative solutions to protect and preserve our planet's rich biodiversity. From the tiniest microorganisms to majestic animals and towering trees, every living organism plays a unique role in NEW YORK, January 3, 2023 (GLOBE NEWSWIRE) — Dante Genomics, a global leader in genomics and precision medicine, is pleased to announce that the Company will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco next week. Andrea Riposati, CEO of Dante Genomics, will present on Tuesday, January Introduction   In this Rare Disease Month, we delved into the challenges surrounding rare diseases, from the complexities of diagnosis to the hurdles in finding suitable treatments. As we observe Rare Disease Day today, it is imperative to raise awareness about these conditions and the daily struggles faced by rare dis Introduction   In recent years, whole genome sequencing (WGS) has emerged as a revolutionary tool in the medical field, offering unprecedented insights into our genetic makeup. One area where WGS holds immense promise is in the prevention, management, and personalized medicine of hypothyroidism. In this blog post, we w SomaLogic’s 7,000-plex SomaScan® Platform will be used in proteomics testing at scale in Europe.   BOULDER, Colo. & L’AQUILA, Italy (July 24, 2023) — SomaLogic Operating Co. Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced its partnership with Dante Genomics, a global leader in ge Introduction   October is a special month dedicated to breast cancer awareness and prevention. It's a time when we reflect on the importance of preserving the health of women worldwide and an opportunity to explore how genetics can play a crucial role in breast cancer prevention and management. We will delve into how W Rare Diseases and their difficult journey   Rare diseases, also known as orphan diseases, affect a relatively small number of individuals compared to more common health conditions. Despite their low prevalence, these disorders can cause significant hardships for patients and their families, often leading to a long and Introduction   In recent years, advancements in genetic research have provided us with valuable insights into the role of genes in various health conditions. One such condition that has gained significant attention is the predisposition to hearing loss. By analyzing the entire genome through a process called Whole Geno Introduction   In the vast landscape of genomics, Whole Genome Sequencing (WGS) has emerged as a powerful tool, offering unprecedented insights into the intricate code that makes us who we are. One area where WGS has proven invaluable is in the realm of rare diseases, where traditional diagnostic methods often fall sho World Children's Day is a special occasion to celebrate our youngest citizens and reflect on how we can improve their health. The Financial Times has published its 7th annual ranking of the 1000 fastest-growing companies in Europe. Dante Genomic ranks among the top 25, registering a 250.5% CAGR in revenues between 2018 and 2021. “Growth comes from every function, from every employee, and especially from delivering applications that impact hum Introduction   On World Pneumonia Day, it is critical to explore innovative approaches to address lung diseases and minimize their impact on global health. Whole genome sequencing (WGS) is revolutionizing the field of genomics and offers enormous potential for the prevention and management of lung disease. Knowing your Recent advances in genetic testing technology, such as WGS, have increased the likelihood of making a genetic diagnosis for patients with rare diseases. As we embrace the excitement of a new school year, let's also prioritize our child's health with Whole genome sequencing and Dante Labs' Pediatric Panel. WGS is revolutionizing the field of skin and dermatological diseases, offering a personalized, preventive, and targeted approach to diagnosis and treatment. An exploration of genetic disorders: why do they occur and when is it necessary to seek out testing and treatment? The human genome is a complex set of instructions that directs our growth and development, and it is highly influential to the outcome of our health. In some instances, the genome can change – or mutate – Introduction   On World Sight Day, we focus our attention on the precious gift of vision and the importance of eye health. This day serves as a reminder that sight is a fundamental part of our well-being. In the world of genetics and healthcare, Whole Genome Sequencing (WGS) analysis and our panels dedicated to eye dis

Parole chiave
Imposta Servizio Legge Bene immobile Biologia Brevetto Commercio Costruzione Industria Musica Progettazione Telematica Trasporto

Ambito Operativo

Dante Labs Srl appartiene al comparto Altri servizi non finanziari e si occupa di Altri servizi non finanziari. Il codice ATECO 72.11.00 corrisponde all'attività: Ricerca e sviluppo sperimentale nel campo delle biotecnologie.

Altri Nomi

Dante Labs Srl è anche conosciuta con i nomi: "DANTE LABS SRL", "DANTE LABS" e "DANTE LABS SOCIETA' A RESPONSABILITA' LIMITATA".

Categoria d'Impresa

La dimensione aziendale colloca Dante Labs Srl nella categoria "piccola impresa" (tra 10 e 49 dipendenti). Il capitale sociale risulta essere di 5.6 M €. I dati economici più recenti si riferiscono all'anno 2023.

Aziende Simili

  • Antropoli Research For Innovation S.r.l. • Rivisondoli, AQ
  • Fondo Ricerca Medica S.r.l. • L'Aquila, AQ
  • Libera Biotech S.r.l. • L'Aquila, AQ
  • Consorzio Di Ricerca Unico D'abruzzo • Avezzano, AQ
  • Med Affairs Support - S.t.p. In Nome Collettivo Di Maria Lauri Ed Aniela Buccella • Oricola, AQ
  • Agroqualis S.r.l. • L'Aquila, AQ
  • Loto Biotech Platform S.r.l. • L'Aquila, AQ
  • Hepika S.r.l. • Avezzano, AQ
  • Green Generation - S.r.l. Semplificata • Sulmona, AQ
Vedi più aziende simili

Domande frequenti su Dante Labs Srl

Quanti dipendenti ha Dante Labs Srl ?
Dante Labs Srl conta 13 dipendenti nel proprio organico.
Qual è il numero IVA di Dante Labs Srl ?
Il numero di Partita IVA di Dante Labs Srl è 01987870662.
Dove è situata la sede di Dante Labs Srl ?
Dante Labs Srl ha sede in Localita' Boschetto, SNC, 67100, L'Aquila (AQ).
Quanti anni ha Dante Labs Srl ?
L'attività di Dante Labs Srl prosegue da 9 anni.
Qual è il volume d'affari di Dante Labs Srl ?
Dante Labs Srl ha fatturato 22.6 M € nell'ultimo esercizio.
Qual è la tendenza del fatturato di Dante Labs Srl ?
I ricavi di Dante Labs Srl mostrano un trend in diminuzione.
Cerved
Soluzioni
  • Atoka Sales
  • Powerbiz
Info Legali
  • Termini di Utilizzo
  • Condizioni d'uso/Disclaimer
  • Cookie Policy
  • Privacy Policy
  • Preferenze consenso
  • CSA STAR Self-Assessment (CAIQ)
  • Informativa privacy ANCIC
  • Informativa privacy info commerciali
© 2026 SpazioDati S.r.l.
Via Adriano Olivetti 13, 38122 Trento (Trento) — REA TN 210089
Capitale sociale € 21.600 — C.F & P.IVA 02241890223 — P.IVA di Gruppo 12022630961
Azienda con Sistema di Gestione della Sicurezza delle Informazioni certificato da Certiquality – UNI CEI EN ISO/IEC 27001:2017
Società soggetta a direzione e controllo da parte di Cerved Group S.p.A.
SpazioDati